SCHEMBL27864358

SCHEMBL27864358

CSc1ccc(Nc2ncncc2C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 1/20 0.49
▸ AURKA O14965 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.41
▸ HPGD P15428 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PIP4K2A P48426 2/20 0.41
▸ PIP4K2C Q8TBX8 2/20 0.41
▸ CYP11B2 P19099 6/20 0.40
▸ CYP11B1 P15538 5/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30380197 0.80 CYP1A2 (0.51) MAP2K1AURKAALDH1A1CYP1A2CYP2D6
SCHEMBL20551942 0.74 ABL1 (0.52) —
SCHEMBL30041610 0.73 EGFR (0.50) RAB9ASMN1; SMN2KDM4E
SCHEMBL1673854 0.73 PIP4K2A (0.47) MAP2K1TRPV1PIP4K2APIP4K2C
SCHEMBL14067140 0.71 CYP3A4 (0.42) HPGDALDH1A1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL30904731 0.70 BCL6 (0.69) ALDH1A1SMN1; SMN2
SCHEMBL20568882 0.70 BCL6 (0.69) ALDH1A1SMN1; SMN2
SCHEMBL9438564 0.68 SLC22A12 (0.37) ALDH1A1CYP1A2CYP3A4POLBCYP11B2
SCHEMBL31419442 0.67 BCL6 (0.40) —
SCHEMBL13970809 0.67 CYP3A4 (0.36) MAP2K1HPGDNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102558155-A Aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of diseases related thereto, such as diabetes and hyperglycemia ARENA PHARM INC 2012-07-11 — — CN disclosed
Send feedback